Emmanuel S. Antonarakis, MD, is the Associate Director for Translational Research with the Masonic Cancer Center, and the Clark Endowed Professor of Medicine at the University of Minnesota in Minneapolis. Dr. Antonarakis’ primary research focuses on drug development and clinical trial design for patients with prostate cancer, as well as cancer genomics. His clinical interest is the management of prostate cancer and other genitourinary malignancies.